{"id":"258845020786-10","name":"Gilead Sciences","registrationDate":"2016-02-23T17:12:58.644+02:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.gilead.com","country":"United states","headAddress":"333 Lakeside","headCity":"California","headPostCode":"CA94404","headPhone":"(1)65 05 74 30 00","boss":"Milligan John","bossTitle":"Mr","bossPosition":"President and Chief Executive Officer","membersCount":3,"membersFTE":"1.25","membership":"AMCHAM EU: http://www.amchameu.eu/&#xd;\n&#xd;\nTHE MENTOR GROUP","memberOrga":"","goal":"Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companyâ€™s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide.","acronym":"GILD","interests":"Competition, Economic and Financial Affairs, Enterprise, Public Health, Trade","euInitiatives":"EU initiatives in relation to HIV/AIDS, Hepatitis B &amp; C and oncology. Joint Action on HIV and co-infection prevention and harm reduction.&#xd;<br />&#xd;<br />- ATMP Regulation&#xd;<br />- EU IP policy&#xd;<br />- EU Relative Efficacy Assessment (EU REA)&#xd;<br />- EU research policy &#xd;<br />- EU trade policy&#xd;<br />- Health Systems Performance Assessment&#xd;<br />- Health Technology Assessment &amp; Market Access&#xd;<br />- Industrial policy&#xd;<br />- Outcomes-based healthcare systems&#xd;<br />- Paediatric Regulation&#xd;<br />- Sustainable Development Goals","lastUp":"2018-03-27T13:27:02.765+02:00","customers":"","costAbsolu":"","costRange":"300000-399999","turnoverAbsolu":0,"turnoverRange":""}